Jacques FellayJacques Fellay is a medical scientist with expertise in infectious diseases and human genomics. He obtained his MD from the University of Lausanne in 2002 and his PhD from University of Utrecht. After a clinical training in infectious diseases in Switzerland and a 4-years postdoctoral fellowship at Duke University, he joined the EPFL in April 2011 with an SNF Professorship.
On top of his EPFL affiliation, Jacques is also Head of Precision Medicine at the University Hospital (CHUV) in Lausanne, Group Leader at the Swiss Institute of Bioinformatics, and Co-director of the Health2030 Genome Center at Campus Biotech in Geneva.
Catherine DehollainShe got the Master Degree in Electrical Engineering in 1982 from EPFL. Then, she worked in Geneva up to 1990 as a Senior Design Engineer in telecommunications at the European research center of Motorola. From 1990 up to 1995, she did her PhD thesis at the Chaire des Circuits et Systemes at EPFL in the domain of impedance broadband matching circuits. Since 1995, she is responsible at EPFL for the RFIC group. She has participated to different Swiss research projects as well as European projects dedicated to data communication of sensors nodes (e.g. MuMoR, Minami European projects) as well as remote powering of sensor nodes. Her main domains of interest are telecom applications (e.g. Impulse radio Ultra-Wide Band, super-regenerative receivers, RFIDs)as well as biomedical applications. She has been the coordinator of European projects (e.g. FP6 SUPREGE, FP7 Ultrasponder)and of Swiss projects (e.g. CAPED CTI project, NEURO-IC SNF project).
Diego Ruben BarrettinoDiego Barrettino (S’93–M’98–SM’06) received the Dipl.-Ing. degree in Electronic Engineering from the University of Buenos Aires, Argentina, in 1997, and the Ph.D. degree in Electrical Engineering from the Swiss Federal Institute of Technology Zurich (ETHZ) in 2004.
He worked at Allegro MicroSystems Inc., from 1997 to 2000, where he was an Analog IC Designer of Hall-effect magnetic sensors. From 2000 to 2004, he was a Ph.D. student and Research Assistant at ETHZ, where he designed chemical and mechanical sensors. In 2004, he moved to the USA where he designed biomedical devices first as a Post-Doctoral Research Associate in the University of Washington, and then as an Assistant Professor in the University of Hawaii. In 2006, he returned to Europe where he joined the Swiss Federal Institute of Technology Lausanne (EPFL) as a Senior Research Scientist for the design and development of biosensors using organic nanotransistors. From 2007 to 2009, he was a Senior Lecturer in the University of Glasgow, U.K., and in the University College Cork, Republic of Ireland, where he designed ultra-low power biomedical devices. From 2009 to 2017, he was Full Professor and Head of the Laboratory of Microelectronics, Bioelectronics and Sensor Systems (LMBS) at the University of Applied Sciences of Southern Switzerland (SUPSI), where he designed smart contact lenses and eye implants. In 2017, he joined both the Lucerne University of Applied Sciences (HSLU) and EPFL as a part-time Senior Research Scientist to continue his work on smart sensor systems.
His research interests are in the fields of physical, chemical, and biomedical microsensors; sensor fusion algorithms; analog and mixed-signal IC design; MEMS; embedded systems; avionics and bioelectronics.
Diego Barrettino is a senior member of the Institute of Electrical and Electronics Engineers (IEEE), a member of the American Institute of Aeronautics and Astronautics (AIAA) and a member of the American Association for the Advancement of Science (AAAS).
Patrick AebischerPatrick Aebischer a achevé une formation en Médecine (1980) et en Neurosciences (1983) aux Universités de Genève et de Fribourg en Suisse.
De 1984 à 1992, Patrick Aebischer a travaillé à Brown University (USA) au sein du Département des Neurosciences et au Département des Biomatériaux et des Organes Artificiels en tant que Professeur assistant, puis Professeur associé.
En 1992, Patrick Aebischer a été nommé Professeur de la Division Autonome de Recherche Chirurgicale et du Centre de Thérapie Génique (DARC) au Centre Hospitalier Universitaire Vaudois (CHUV) à Lausanne.
En 1999, Le Conseil Fédéral a nommé Patrick Aebischer en tant que Président de l'Ecole Polytechnique Fédérale de Lausanne (EPFL). Il a pris ses fonctions à la Présidence de lEPFL en mars 2000, position qu'il a occupée jusqu'au 31 décembre 2016.
Patrick Aebischer est membre de maintes sociétés professionnelles, tant en Europe quaux Etats-Unis.
Patrick Aebischer a fondé trois start-up de biotechnologies. Il siège au conseil d'administration de Lonza, de Logitech et de Nestlé. Il préside également l'advisory board du Novartis Venture Fund. Patrick Aebischer est membre du conseil de fondation du Festival de Jazz de Montreux, du Festival de Verbier et de la Fondation Jacobs.
Les recherches quil poursuit actuellement dans son laboratoire se concentrent sur le développement d'approches de thérapie cellulaire et de transfert génique pour le traitement des maladies neurodégénératives.